MAPK3 and cancer: SRC and ERK1/2 regulate cancer cell migration, invasion and metastasis [13] and, therefore, we tested whether combinations of MEK and SRC inhibitors could synergise to block invasion using a 3D organotypic collagen I invasion assay [33].